Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases

Lignende værker

• Efficacy and Safety Evaluation of Intrathecal Pemetrexed in EGFR-mutated NSCLC Patients 
with Leptomeningeal Metastases
  af: Tianli ZHANG, et al.
  Udgivet: (2025-08-01)
• Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression
  af: White, Maya N, et al.
  Udgivet: (2021)
• Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR‐mutation non‐small cell lung cancer: A phase II single‐arm prospective clinical trial
  af: Lu, Zhi‐qin, et al.
  Udgivet: (2020)
• Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series
  af: Li, Huiying, et al.
  Udgivet: (2019)
• Osimertinib administration via nasogastric tube in an EGFR‐T790M‐positive patient with leptomeningeal metastases
  af: Takeda, Takayuki, et al.
  Udgivet: (2017)